By Taimour Zaman, Founder, AltFunds Global
Growth equity occupies a sweet spot in private capital. It is not seed stage, and it is not a full buyout. These firms back businesses that already have traction but need fuel to scale. Here is how the segment works and who the major players are.
What growth equity is and why it matters
Growth equity is capital deployed into established, revenue-generating companies (often $10M+ in revenue) to accelerate expansion: new markets, new product lines, or acquisitions. Unlike early-stage venture, these companies have proven the model. Unlike buyouts, the founder usually keeps control.
The appeal is upside with more guardrails than pure venture. But growth equity is not risk-free. Execution, valuation, and market cycles still matter. Cliffwater has called the segment private capital's overlooked sweet spot, and firms like General Atlantic, Summit Partners, and TA Associates are credited with pioneering the approach.
The broader private capital context
Growth equity sits inside a very large ecosystem. McKinsey's private markets research puts private credit assets under management near $2 trillion as of the end of 2023, roughly ten times the 2009 level, and total private markets AUM above $13 trillion with several trillion in dry powder waiting to be deployed. Capital has flowed deeply into alternatives, and growth equity is one of its most durable lanes.
The firms to know
- TA Associates: growth private equity across technology, healthcare, consumer, financial services, and business services. More than 560 portfolio companies since inception.
- Summit Partners: growth and venture, typically in tech, healthcare, and growth products.
- General Atlantic: global growth equity, historically grouped with Summit and TA as the pioneers of the category.
- Insight Partners, Accel-KKR, and Battery Ventures: software and technology platforms, often straddling the venture and growth line.
Many of these firms invest across stages and take minority or majority positions depending on the deal. The lines blur in practice.
What these firms look for
- A proven, scalable business model. Growth equity expects metrics, customers, and product-market fit, not experiments.
- Strong management with founder alignment: a clear vision and a track record of execution.
- Room to scale, whether by geography, product line, or acquisition.
- Financial discipline: margins, sustainable growth, and efficient capital deployment alongside the growth story.
- Exit clarity. Their role is to grow the business toward an IPO, acquisition, or secondary sale, so they pick businesses where those paths are credible.
The risks worth flagging
- Valuation risk: paying ahead of what future growth delivers.
- Execution risk: scaling introduces new operational, market, and infrastructure challenges.
- Liquidity and time horizon: these are illiquid positions, locked until exit.
- Market cycles: slower periods compress multiples and delay exits.
- Blended structures: some "growth equity" deals carry leverage or debt features. Read the structure, not the label.
The takeaway
Growth equity rewards companies that have proven the model and can absorb serious capital with discipline. For operators, the preparation is the same as any institutional process: real metrics, a credible growth runway, and a file organized the way a committee expects to see it.
Preparing for a growth capital conversation? Visit us at AltFunds Global.
Disclaimer
This article is provided for general educational and informational purposes only. It does not constitute financial, legal, or tax advice, and it is not an offer, solicitation, or recommendation to buy or sell any financial instrument. References to third-party firms and research are illustrative market references, not endorsements or recommendations. AltFunds Global is a global financial advisory firm; it is not a bank, lender, fund, custodian, broker-dealer, or placement agent. Readers should seek independent professional advice (legal, tax, financial) before making any decisions. Past case studies do not guarantee future results. No liability is accepted for any loss arising from the use of this material.